Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot
Code deleted, see 80335, 80336, 80337

Official Description

Desipramine

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 80160 refers to a laboratory test specifically designed to measure the levels of desipramine in the blood. Desipramine, which is also known by its brand name Norpramin, belongs to a class of medications called tricyclic antidepressants. These medications are primarily utilized in the treatment of various mental health conditions, including depression and anxiety or panic disorders. Additionally, desipramine is prescribed for managing neuropathic pain, attention deficit-hyperactivity disorder (ADHD), bulimia, and persistent hives of unknown origin. The process of obtaining a blood sample for this test involves a procedure known as venipuncture, which is separately reportable. Once the blood sample is collected, the serum is analyzed using a sophisticated technique called liquid chromatography-tandem mass spectrometry, which allows for precise measurement of the drug levels in the bloodstream. This test is crucial for monitoring therapeutic levels of desipramine, ensuring that patients receive the appropriate dosage for effective treatment while minimizing potential side effects.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The desipramine level test (CPT® Code 80160) is indicated for several specific conditions and circumstances, which include:

  • Depression - The test is used to monitor desipramine levels in patients being treated for depressive disorders.
  • Anxiety/Panic Disorders - It helps in assessing the effectiveness of desipramine in managing anxiety and panic-related symptoms.
  • Neuropathic Pain - The test is indicated for patients using desipramine to alleviate pain resulting from nerve damage.
  • Attention Deficit-Hyperactivity Disorder (ADHD) - It is utilized to monitor therapeutic levels in patients diagnosed with ADHD who are prescribed desipramine.
  • Bulimia - The test is relevant for patients with bulimia who are receiving treatment with desipramine.
  • Persistent Hives of Unknown Etiology - It is indicated for patients experiencing chronic hives without a known cause, where desipramine may be part of the treatment plan.

2. Procedure

The procedure for conducting the desipramine level test involves several key steps, which are outlined as follows:

  • Step 1: Patient Preparation - Prior to the blood draw, the patient may be instructed to avoid certain medications or foods that could interfere with the test results. It is essential to ensure that the patient is adequately informed about the procedure and any necessary preparations.
  • Step 2: Venipuncture - A qualified healthcare professional performs a venipuncture to obtain a blood sample. This involves inserting a needle into a vein, typically in the arm, to draw the required volume of blood. The venipuncture is a separately reportable procedure and must be documented accordingly.
  • Step 3: Serum Separation - After the blood sample is collected, it is processed to separate the serum from the cellular components. This step is crucial as the serum is the portion of the blood that will be tested for desipramine levels.
  • Step 4: Testing - The serum is then subjected to analysis using liquid chromatography-tandem mass spectrometry. This advanced testing method allows for accurate quantification of desipramine levels in the serum, providing essential data for the healthcare provider.

3. Post-Procedure

After the desipramine level test is completed, the healthcare provider will review the results to determine if the desipramine levels are within the therapeutic range. Depending on the findings, adjustments to the patient's medication regimen may be necessary. Patients may be advised to monitor for any side effects or symptoms related to their treatment. Follow-up appointments may be scheduled to reassess the patient's condition and the effectiveness of the treatment plan. It is also important for healthcare providers to document the results and any subsequent actions taken based on the test outcomes.

Short Descr ASSAY OF DESIPRAMINE
Medium Descr DRUG SCREEN QUANTITATIVE DESIPRAMINE
Long Descr Desipramine
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 9 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Items and Services Packaged into APC Rates
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE Not applicable/unspecified.
CCS Clinical Classification 235 - Other Laboratory
Date
Action
Notes
2015-01-01 Deleted Code deleted, see 80335, 80336, 80337
2013-01-01 Changed Medium description changed per AMA 2013 corrections document dated January 25, 2013.
1993-01-01 Added First appearance in code book in 1993.
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"